Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Sustainable Bio Solutions Aabenraa K/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   9.1% 7.7% 5.8% 6.3% 1.5% 2.2% 15.8% 15.5%   Credit score (0-100)   28 33 39 36 76 65 12 13   Credit rating   BB BB BBB BBB A BBB BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 -0.0 -39.4 -2.8 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -2,985 -3,497 -3,224 -2,700 28,321 25,870 0.0 0.0   EBITDA   -2,985 -3,497 -3,412 -5,526 16,775 22,346 0.0 0.0   EBIT   -2,985 -3,497 -3,412 -5,526 5,931 -2,653 0.0 0.0   Pre-tax profit (PTP)   -2,999.7 -3,804.7 -6,005.7 -19,540.1 -26,789.1 -38,380.3 0.0 0.0   Net earnings   -2,999.7 -3,804.7 -6,005.7 -19,540.1 -26,789.1 -38,380.3 0.0 0.0   Pre-tax profit without non-rec. items   -3,000 -3,497 -3,412 -5,526 -26,789 -38,380 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   14,241 0.0 0.0 0.0 466,691 450,750 0.0 0.0   Shareholders equity total   -2,999 6,803 12,809 -32,349 -59,138 -97,519 -97,520 -97,520   Interest-bearing liabilities   19,302 0.0 0.0 0.0 561,037 570,790 97,520 97,520   Balance sheet total (assets)   17,644 29,528 170,702 367,412 600,801 508,055 0.0 0.0   Net Debt   16,296 0.0 0.0 0.0 479,324 570,786 97,520 97,520     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -2,985 -3,497 -3,224 -2,700 28,321 25,870 0.0 0.0   Gross profit growth   0.0% -17.1% 7.8% 16.2% 0.0% -8.7% -100.0% 0.0%   Employees   0 0 1 1 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 200.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   17,644 29,528 170,702 367,412 600,801 508,055 0 0   Balance sheet change%   0.0% 67.4% 478.1% 115.2% 63.5% -15.4% -100.0% 0.0%   Added value   -2,984.8 -3,496.7 -3,411.8 -5,525.6 5,931.5 22,345.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   14,241 -14,241 0 0 455,847 -40,939 -450,750 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 105.8% 204.6% 20.9% -10.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -14.4% -13.9% -3.4% -1.9% 1.1% -0.4% 0.0% 0.0%   ROI %   -15.4% -14.3% -3.4% -1.9% 1.2% -0.4% 0.0% 0.0%   ROE %   -17.0% -31.1% -61.2% 200.0% -4.9% -3.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -14.5% 100.0% 100.0% 0.0% -5.0% -8.9% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -545.9% 0.0% 0.0% 0.0% 2,857.3% 2,554.4% 0.0% 0.0%   Gearing %   -643.7% 0.0% 0.0% 0.0% -948.7% -585.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 0.0% 0.0% 0.0% 11.7% 6.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.5 0.0 0.0 0.0 1.0 0.5 0.0 0.0   Current Ratio   2.5 0.0 0.0 0.0 1.0 0.5 0.0 0.0   Cash and cash equivalent   3,006.1 0.0 0.0 0.0 81,713.2 4.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,030.7 0.0 0.0 0.0 6,261.8 -56,177.3 -48,759.9 -48,759.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 -3,412 -5,526 1,977 7,449 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 -3,412 -5,526 5,592 7,449 0 0   EBIT / employee   0 0 -3,412 -5,526 1,977 -884 0 0   Net earnings / employee   0 0 -6,006 -19,540 -8,930 -12,793 0 0